Scarica l'app Stockscreener
1.23
0.81%
-0.01
Dopo l'orario di chiusura:
1.23
Precedente Chiudi:
$1.24
Aprire:
$1.26
Volume 24 ore:
53,587
Relative Volume:
0.87
Capitalizzazione di mercato:
$23.69M
Reddito:
-
Utile/perdita netta:
$-8.83M
Rapporto P/E:
-1.6822
EPS:
-0.7312
Flusso di cassa netto:
$-8.01M
1 W Prestazione:
+8.85%
1M Prestazione:
+13.89%
6M Prestazione:
+15.49%
1 anno Prestazione:
-15.75%
Intervallo 1D:
$1.22
$1.2756
Intervallo di 1 settimana:
$1.10
$1.29
Portata 52W:
$0.76
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
Nome
Cocrystal Pharma Inc
Settore
Industria
Telefono
(786) 459-1831
Indirizzo
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.23 | 23.89M | 0 | -8.83M | -8.01M | -0.7312 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-07-08 | Iniziato | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Borsa (COCP) Ultime notizie
Cocrystal Pharma Completes Dosing in Norovirus Phase 1b Study - TipRanks
Cocrystal Pharma (COCP) Advances Norovirus Antiviral Study Amid High Price-to-Sales Valuation - GuruFocus
Cocrystal Pharma (COCP) finishes dosing human norovirus study, eyes first efficacy readout next - Stock Titan
Cocrystal completes dosing in norovirus drug trial By Investing.com - Investing.com India
No serious adverse events reported as a norovirus drug study reaches final dosing - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Cocrystal Pharma Inc (COCP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cocrystal Pharma: The Strategic Reset Investors May Be Missing - Yahoo Finance
Cocrystal Pharma Inc. (COCP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cocrystal (COCP) director Brosgart files with zero reported holdings - Stock Titan
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Cocrystal (COCP) Q1 2026 Results: The EPS Result Is Below Expectation in the Reported Period; After Earnings: The Share Price Adds 0.87%Dividend Increase Stocks - vinanet.vn
Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial - Clinical Leader
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma Adds Veteran Leader to Board of Directors - TipRanks
Cocrystal Pharma (NASDAQ: COCP) names Carol L. Brosgart to its board - Stock Titan
Cocrystal Pharma strengthens board with antiviral expert appointment - TipRanks
Cocrystal Pharma appoints Carol Brosgart to board to bolster antiviral development - TradingView
Cocrystal Pharma (COCP) appoints antiviral veteran to board - Stock Titan
Cocrystal Pharma Appoints Antiviral Drug Expert Carol Brosgart to Board - citybiz
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol Brosgart to board of directors - Investing.com
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - The Manila Times
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
A Gilead veteran joins Cocrystal’s board to guide antiviral drug development - Stock Titan
Cocrystal Pharma Q2 Results: EPS Loss Widens to $(0.23), Misses Estimate - scanx.trade
Cocrystal Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cocrystal Pharma (COCP) flags going-concern risk amid Q2 2026 loss and $5M raise - Stock Titan
Cocrystal Pharma’s single oral drug for multiple viruses - drugdiscoverytrends.com
Cocrystal Pharma Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Cocrystal Pharma Inc (COCP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cocrystal Pharma (COCP) adds OPKO and insiders as major holders - Stock Titan
Cocrystal Pharma director Phillip Frost buys $9,816 in stock By Investing.com - Investing.com South Africa
Phillip Frost details 13.9% Cocrystal Pharma (COCP) stake in update - Stock Titan
Cocrystal Pharma director Phillip Frost buys $9,816 in stock - Investing.com
Cocrystal Pharma (COCP) insider buys 10,000 shares via trust - Stock Titan
Cocrystal Pharma, Inc. (COCP) insider-linked trust purchases 75,000 shares - Stock Titan
OPKO Health invests $5 million in Cocrystal Pharma By Investing.com - Investing.com
OPKO Health Boosts Stake in Cocrystal Pharma Financing - TipRanks
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share - TradingView
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health - Stock Titan
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health - globenewswire.com
OPKO Buys 5.47M Cocrystal Shares Ahead of Late-2026 Norovirus Data - Stock Titan
Cocrystal Pharma, Inc. Revenue Breakdown – NASDAQ:COCP - TradingView
Cocrystal Pharma Inc (COCP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cocrystal Pharma, Inc. announced that it has received $5 million in funding from OPKO Health, Inc. - marketscreener.com
Cocrystal Pharma (COCP) Edges Higher Near Support ZoneFundamentals - vinanet.vn
Cocrystal Pharma Inc (COCP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cocrystal Pharma Inc (COCP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cocrystal Pharma Inc Azioni (COCP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):